Pharmacology & ToxicologyFrontiers in EndocrinologyPeer-reviewed
The Novel Chimeric Multi-Agonist Peptide (GEP44) Reduces Energy Intake and Body Weight in Male and Female Diet-Induced Obese Mice in a Glucagon-Like Peptide-1 Receptor-Dependent Manner
James Ernest Blevins, Mackenzie K. Honeycutt, Jared D. Slattery…·Christian Ludwig Roth
This study shows that the chimeric peptide GEP44 reduces body weight and energy intake in diet-induced obese mice, primarily through GLP-1R signaling, with some GLP-1R-independent effects in males.
6 citations